期刊文献+

自发性细菌性腹膜炎预防治疗的问题及对策 被引量:2

下载PDF
导出
摘要 口服氟喹诺酮类抗菌药物,选择性肠道去污染是预防自发性细菌性腹膜炎(SBP)的重要措施。但由此而诱发耐药菌株产生,并使SBP或其他感染的病原菌株发生变化。进一步筛选SBP的危险因素,严格控制预防性抗菌治疗的对象,可能是解决问题的对策。
出处 《国外医学(消化系疾病分册)》 2002年第3期180-182,共3页
  • 相关文献

参考文献20

  • 1[1]Thuluvath PJ et al. Am J Gastroenterol, 2001; 96(4): 1232~1236
  • 2[2]Dhiman RK et al. Am J Gastrenterol, 2000; 95(1): 233~238
  • 3[3]Chu CM. Am J Gastroenterol, 2000; 95(8): 2126~2127
  • 4[4]Garcia-Tsao G. Gestroenterology, 1999; 117(2): 495~499
  • 5[5]Piddocle LJV. BMJ, 1999; 317: 1029~1030
  • 6[6]Aparicio JR et al. Med Clin, 1999; 113(7): 241~245
  • 7[7]Ortiz J et al. Hepatology, 1999; 29(4): 1004~1069
  • 8[8]Eledrisi MS et al. Am J Gastroenterol, 2000; 95(4): 1110~1111
  • 9[9]de la Fuente Aguade J et al. Infection, 1999; 27(3): 224~227
  • 10[10]Sabat M et al. Am J Gastroenterol, 1998; 93(12): 2457~2462

同被引文献36

  • 1李咏梅,贺俊花.益生菌预防肝硬化自发性腹膜炎疗效观察[J].中国误诊学杂志,2009,9(3):576-577. 被引量:4
  • 2刘芙成,斯锞.双歧杆菌联合乳果糖对自发性细菌性腹膜炎的预防作用[J].临床荟萃,2005,20(20):1174-1175. 被引量:3
  • 3Chang CS,Yang SS,Kao CH,et al.Small intestinal bacterial cvergrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis[J].Scand J Gastroenterol,2001,36(1):92-96.
  • 4Femandez J,Navasa M,Gomez J,et al.Bacterial infections in cirrhosis:epidemiological changes with invasive procedures and norfloxacin prophylaxis[J].Hepatology,2002,35(1):140-148.
  • 5Campillo B,Dupeyron C,Richardet JP.Epidemiology of hospital-acquired infections in cirrhotic patients:effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis[J].Epidemiol Infect,2001,127(3):443-450.
  • 6Kirpich IA, Mcclain CJ. Probiotics in the treatment of the liverdiseases[J]. J Am Coll Nutr,2012,31(1): 14-23.
  • 7European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis [J]. JHepatol,2010,53 (3): 397-417.
  • 8Runyon BA,AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis : an update [J]. Hepatology,2009,49(6): 2087-2107.
  • 9Pande C,Kumar A,Sarin SK. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis : a double-blind placebo-controlled randomized-controlled trial[J]. Eur J Gastroenterol Hepatol,2012,24(7): 831-839.
  • 10Imani Fooladi AA,Mahmoodzadeh Hosseini H,Nourani MR,et al. Probiotic as a novel treatment strategy against liver disease [J]. Hepat Mon,2013,13(2): e7521.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部